0001104659-23-027622.txt : 20230302
0001104659-23-027622.hdr.sgml : 20230302
20230302070016
ACCESSION NUMBER: 0001104659-23-027622
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230302
DATE AS OF CHANGE: 20230302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLACKSON TIMOTHY P
CENTRAL INDEX KEY: 0001242992
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40869
FILM NUMBER: 23696364
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theseus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001745020
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830712806
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 314 MAIN STREET, SUITE 04-200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (857) 400-9491
MAIL ADDRESS:
STREET 1: 314 MAIN STREET, SUITE 04-200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
tm237858-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-03-01
0
0001745020
Theseus Pharmaceuticals, Inc.
THRX
0001242992
CLACKSON TIMOTHY P
C/O THESEUS PHARMACEUTICALS, INC.
314 MAIN STREET
CAMBRIDGE
MA
02142
1
1
0
0
President and CEO
Restricted Stock Units
2023-03-01
4
A
0
45625
0.00
A
Common Stock
45625
45625
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.
The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 25% of the RSUs vesting on March 1, 2024 and 1/16th of the RSUs vesting quarterly thereafter, subject to the Reporting Person's continuous service with the issuer. The RSUs have no expiration date.
/s/ Bradford Dahms - Attorney-in-Fact
2023-03-02